Clinical Trial Update: Topical ASP-1001 (Contrast Media Formulation) and the Acute Response to Nasal Allergen Challenge (NAC) [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update reports the Phase 2/3 results for topical ASP-1001 in allergic rhinitis, with study results posted in 2013 after completion. Sponsored by …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• ASP-1001

Snippet

Sponsor: University of Chicago | Conditions: Allergic Rhinitis | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2013-07-10